. (open access) shows that athletes of the mind � chess grandmasters � show the same longevity advantage as athletes of the body.
.
.
refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.